Symbiotec Pharmalab Ltd IPO
Listed · Mainboard · BSE, NSE
Last updated: · Compiled by IPONOVA Editorial Desk · How we source data
IPO Details
| Price Band | ₹938.00–₹988.00 |
|---|---|
| Lot Size | 15 shares |
| Issue Size | ₹1,757 Cr |
| Open Date | 24 Aug 26 |
| Close Date | 27 Aug 26 |
| Listing Date | 01 Sep 26 |
| Exchange | BSE, NSE |
| Subscription | 75.08x |
About Symbiotec Pharmalab Ltd
Symbiotec Pharmalab Ltd. is a pharmaceutical and biotechnology company engaged in the development and manufacturing of active pharmaceutical ingredients (APIs), nutritional ingredients, and specialty products.
Anchor Investor Allotment
Total Investors34
Total Shares5,325,909
Total Allocation99.98%
Total Investment₹526.20 Cr
Allotment Date28 Aug 2026
30-Day Lock-in Ends13 Oct 2026
90-Day Lock-in Ends08 Jan 2027
| Anchor Investor Name | Eq. Shares | Allocation % | Bid Price | Investment Amount | 30-Day Lock-in | 90-Day Lock-in |
|---|---|---|---|---|---|---|
| ICICI Prudential Smallcap Fund | 607,290 | 11.40% | ₹988.00 | ₹60.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Ashoka WhiteOak ICAV - Ashoka WhiteOak Emerging Markets Equity Fund | 455,475 | 8.55% | ₹988.00 | ₹45.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Motilal Oswal Small Cap Fund | 455,475 | 8.55% | ₹988.00 | ₹45.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| HDFC Mutual Fund - HDFC Pharma and Healthcare Fund | 404,865 | 7.60% | ₹988.00 | ₹40.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Mirae Asset Health Care Fund | 354,270 | 6.65% | ₹988.00 | ₹35.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Prazim Trading and Investment Company Private Limited | 253,050 | 4.75% | ₹988.00 | ₹25.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Manulife Global Fund - India Equity Fund | 253,050 | 4.75% | ₹988.00 | ₹25.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Mahindra Manulife Small Cap Fund | 253,050 | 4.75% | ₹988.00 | ₹25.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Edelweiss Trusteeship Co Ltd AC-Edelweiss MF AC Edelweiss Large Cap Fund | 202,425 | 3.80% | ₹988.00 | ₹20.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Tata AIA Life Insurance Company Limited A/C Whole Life Aggressive Growth Fund ULIF 010 04/01/07 WLA 110 | 161,955 | 3.04% | ₹988.00 | ₹16.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Bajaj Life Insurance Limited | 161,955 | 3.04% | ₹988.00 | ₹16.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Tata Flexi Cap Fund | 151,830 | 2.85% | ₹988.00 | ₹15.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Baroda BNP Paribas Focused Fund | 101,235 | 1.90% | ₹988.00 | ₹10.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Tata India Pharma and Healthcare Fund | 101,220 | 1.90% | ₹988.00 | ₹10.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Bharti AXA Life Insurance Company Limited | 101,220 | 1.90% | ₹988.00 | ₹10.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| TIMF Holdings | 101,220 | 1.90% | ₹988.00 | ₹10.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| ValueQuest Founders Conviction LVF | 101,220 | 1.90% | ₹988.00 | ₹10.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Susquehanna Pacific Pty Ltd | 101,220 | 1.90% | ₹988.00 | ₹10.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Singularity Equity Fund I | 101,220 | 1.90% | ₹988.00 | ₹10.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Mirae Asset Multi Asset Allocation Fund | 101,205 | 1.90% | ₹988.00 | ₹10.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| ICICI Lombard General Insurance Company Limited | 88,331 | 1.66% | ₹988.00 | ₹8.73 Cr | 13 Oct 2026 | 08 Jan 2027 |
| BNP Paribas Financial Markets - ODI | 88,330 | 1.66% | ₹988.00 | ₹8.73 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Groww Mutual Fund - Groww Multi Cap Fund | 70,860 | 1.33% | ₹988.00 | ₹7.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Baroda BNP Paribas Health and Wellness Fund | 60,720 | 1.14% | ₹988.00 | ₹6.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Citigroup Global Markets Mauritius Private Limited | 57,963 | 1.09% | ₹988.00 | ₹5.73 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Edelweiss Trusteeship Co Ltd AC-Edelweiss MF AC - Edelweiss Recently Listed IPO Fund | 50,625 | 0.95% | ₹988.00 | ₹5.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| HDFC Mutual Fund - HDFC MNC Fund | 50,610 | 0.95% | ₹988.00 | ₹5.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| TRUSTMF Multi Cap Fund | 50,610 | 0.95% | ₹988.00 | ₹5.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| TRUSTMF Large & Mid Cap Fund | 50,610 | 0.95% | ₹988.00 | ₹5.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Flumen Investment Trust - 1729 Growth Fund I | 50,610 | 0.95% | ₹988.00 | ₹5.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| RMS Growth Fund - RMS Growth Fund Scheme 1 | 50,610 | 0.95% | ₹988.00 | ₹5.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| ITI Multi Cap Fund | 50,610 | 0.95% | ₹988.00 | ₹5.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| ITI Flexi Cap Fund | 50,610 | 0.95% | ₹988.00 | ₹5.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| Groww Mutual Fund - Groww Small Cap Fund | 30,360 | 0.57% | ₹988.00 | ₹3.00 Cr | 13 Oct 2026 | 08 Jan 2027 |
| TOTAL (34 investors) | 5,325,909 | 99.98% | ₹526.20 Cr | |||
Lock-in dates calculated from allotment date (30 & 90 calendar days, adjusted to next NSE trading day as per exchange holiday calendar).
For live subscription data, allotment status and full IPO analysis, visit IPONOVA — India's IPO Intelligence Platform.
Frequently Asked Questions
- When does the Symbiotec Pharmalab Ltd IPO open and close?
- The Symbiotec Pharmalab Ltd IPO opens for subscription on 24 Aug 26. It closes on 27 Aug 26.
- What is the price band of Symbiotec Pharmalab Ltd IPO?
- The price band of Symbiotec Pharmalab Ltd IPO is ₹938.00 to ₹988.00 per share.
- What is the minimum lot size for Symbiotec Pharmalab Ltd IPO?
- The minimum lot size for Symbiotec Pharmalab Ltd IPO is 15 shares, requiring a minimum investment of ₹14,820.
- When will Symbiotec Pharmalab Ltd list on stock exchanges?
- Symbiotec Pharmalab Ltd is expected to list on BSE, NSE on 01 Sep 26.
- How can I check Symbiotec Pharmalab Ltd IPO allotment status?
- You can check Symbiotec Pharmalab Ltd IPO allotment status on IPONOVA after the basis of allotment is finalized, or via the registrar's website using your PAN number, application number, or DP/Client ID.
- How to apply for Symbiotec Pharmalab Ltd IPO?
- You can apply for Symbiotec Pharmalab Ltd IPO through your broker's app (Zerodha, Groww, Upstox, etc.) or via UPI-enabled net banking using ASBA. Submit the application during the IPO subscription window with the price within the band ₹938.00 to ₹988.00 per share.
Data Sources & Verification
This page aggregates publicly available data for the Symbiotec Pharmalab Ltd IPO from the following authoritative sources:
- SEBI — Red Herring Prospectus (RHP) and regulatory filings · sebi.gov.in
- BSE Limited — Issue circulars, subscription data, listing notices · bseindia.com
- National Stock Exchange of India (NSE) — Public issue data, listing data · nseindia.com
- Registrar to the Issue — Allotment status (Link Intime, KFin Technologies, Bigshare Services, MUFG Intime)
Subscription, allotment and listing data is refreshed throughout each IPO's issue window directly from the exchanges and registrars listed above. Always read the official offer document (RHP) before applying. For corrections, contact IPONOVA Editorial Desk.
Disclaimer: IPONOVA is an information platform only. We are not SEBI-registered investment advisors.
All data is presented for educational and informational purposes and is sourced from publicly available filings on BSE, NSE and SEBI.
Investment in securities market is subject to market risks. Read all related documents carefully before investing.
Past performance is not indicative of future returns. Please consult a SEBI-registered investment advisor before making any investment decisions.